Targeting N-type and T-type calcium channels for the treatment of pain

Drug Discovery Today

Volumn 11, Issue 5-6, 2006, Pages 245-253

  McGivern, Joseph G ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ANALGESICS; ANIMALS; CALCIUM CHANNELS, N-TYPE; CALCIUM CHANNELS, T-TYPE; CHRONIC DISEASE; HUMANS; OMEGA-CONOTOXINS; PAIN; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 33645329856     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(05)03662-7     Document Type: Review

References (129)

1. Stewart W.F. Lost productive time and cost due to common pain conditions in the US workforce JAMA 290 2003 2443 2454
2. Levine J.D. Peptides and the primary afferent nociceptor J. Neurosci. 13 1993 2273 2286
3. Dickenson A.H. The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord Gen. Pharmacol. 28 1997 633 638
4. Bennett G.J. Update on the neurophysiology of pain transmission and modulation: focus on the NMDA-receptor J. Pain Symptom Manage. 19 Suppl. 2000 2 6
5. Larson A.A. Pain threshold changes in adjuvant-induced inflammation: a possible model of chronic pain in the mouse. Pharmacol Biochem. Behav. 24 1986 49 53
6. Colpaert F.C. Evidence that adjuvant arthritis in the rat is associated with chronic pain Pain 28 1987 201 222
7. Hargreaves K. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia Pain 32 1988 77 88
8. Xiao H.S. Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain Proc. Natl. Acad. Sci. U. S. A. 99 2002 8360 8365
9. Wood J.N. Ion channel activities implicated in pathological pain Novartis Found. Symp. 261 2004 32 40
10. Hilaire C. Calcium dependence of axotomized sensory neurons excitability Neurosci. Lett. 380 2005 330 334
11. McCleane G. Pharmacological strategies in relieving neuropathic pain Expert Opin. Pharmacother. 5 2004 1299 1312
12. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man Pain 33 1988 87 107
13. Seltzer Z. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury Pain 43 1990 205 218
14. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat Pain 50 1992 355 363
15. McGivern J.G., McDonough S.I. Voltage-gated calcium channels as targets for the treatment of chronic pain Curr. Drug Targets CNS Neurol. Disord. 3 2004 457 478
16. Miljanich G.P. Ziconotide: neuronal calcium channel blocker for treating severe chronic pain Curr. Med. Chem. 11 2004 3029 3040
17. Bourinet E. Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception EMBO J. 24 2005 315 324
18. Westenbroek R.E. Biochemical properties and subcellular distribution of an N-type calcium channel alpha 1 subunit Neuron 9 1992 1099 1115
19. Zamponi G.W. Regulation of presynaptic calcium channels by synaptic proteins J. Pharmacol. Sci. 92 2003 79 83
20. Westenbroek R.E. Localization of Ca2+ channel subtypes on rat spinal motor neurons, interneurons, and nerve terminals J. Neurosci. 18 1998 6319 6330
21. Luo Z.D. Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats J. Neurosci. 21 2001 1868 1875
22. Newton R.A. Dorsal root ganglion neurons show increased expression of the calcium channel alpha2delta-1 subunit following partial sciatic nerve injury Brain Res. Mol. Brain Res. 95 2001 1 8
23. Abe M. Changes in expression of voltage-dependent ion channel subunits in dorsal root ganglia of rats with radicular injury and pain Spine 27 2002 1517 1524
24. Cizkova D. Localization of N-type Ca2+ channels in the rat spinal cord following chronic constrictive nerve injury Exp. Brain Res. 147 2002 456 463
25. Yokoyama K. Plastic change of N-type Ca channel expression after preconditioning is responsible for prostaglandin E2-induced long-lasting allodynia Anesthesiology 99 2003 1364 1370
26. Olivera B.M. Purification and sequence of a presynaptic peptide toxin from Conus geographus venom Biochemistry 23 1984 5087 5090
27. Olivera B.M. Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using omega-conotoxin from Conus magus venom Biochemistry 26 1987 2086 2090
28. Stoehr S.J., Dooley D.J. Characteristics of [125I]omega-conotoxin MVIIA binding to rat neocortical membranes Neurosci. Lett. 161 1993 113 116
29. Lewis R.J. Novel omega-conotoxins from Conus catus discriminate among neuronal calcium channel subtypes J. Biol. Chem. 275 2000 35335 35344
30. Atlas D. Functional and physical coupling of voltage-sensitive calcium channels with exocytotic proteins: ramifications for the secretion mechanism J. Neurochem. 77 2001 972 985
31. Santicioli P. Release of calcitonin gene-related peptide like-immunoreactivity induced by electrical field stimulation from rat spinal afferents is mediated by conotoxin-sensitive calcium channels Neurosci. Lett. 136 1992 161 164
32. Harding L.M. Voltage-dependent calcium channel subtypes controlling somatic substance P release in the peripheral nervous system Prog. Neuropsychopharmacol. Biol. Psychiatry 23 1999 1103 1112
33. Smith M.T. The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices Pain 96 2002 119 127
34. Matthews E.A., Dickenson A.H. Effects of spinally delivered N- and P-type voltage-dependent calcium channel antagonists on dorsal horn neuronal responses in a rat model of neuropathy Pain 92 2001 235 246
35. Chaplan S.R. Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia J. Pharmacol. Exp. Ther. 269 1994 1117 1123
36. Bowersox S.S. Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain J. Pharmacol. Exp. Ther. 279 1996 1243 1249
37. Scott D.A. Actions of intrathecal omega-conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat Eur. J. Pharmacol. 451 2002 279 286
38. Hatakeyama S. Differential nociceptive responses in mice lacking the alpha(1B) subunit of N-type Ca(2+) channels Neuroreport 12 2001 2423 2427
39. Kim C. Altered nociceptive response in mice deficient in the alpha(1B) subunit of the voltage-dependent calcium channel Mol. Cell. Neurosci. 18 2001 235 245
40. Saegusa H. Suppression of inflammatory and neuropathic pain symptoms in mice lacking the N-type Ca2+ channel EMBO J. 20 2001 2349 2356
41. Atanassoff P.G. Ziconotide, a new N-type calcium channel blocker, administered intrathecally for acute postoperative pain Reg. Anesth. Pain Med. 25 2000 274 278
42. Taqi D. Intrathecal ziconotide effect on neuropathic symptoms and potential for adjunctive use with opiates: a retrospective review in 25 patients Pain Med. 3 2002 180 181
43. Staats P.S. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial J. Am. Med. Assoc. 291 2004 63 70
44. Penn R.D., Paice J.A. Adverse effects associated with the intrathecal administration of ziconotide Pain 85 2000 291 296
45. Takahara A. Antisympathetic and hemodynamic property of a dual L/N-type Ca(2+) channel blocker cilnidipine in rats Eur. J. Pharmacol. 434 2002 43 47
46. Wright C.E. Cardiovascular and autonomic effects of omega-conotoxins MVIIA and CVID in conscious rabbits and isolated tissue assays Br. J. Pharmacol. 131 2000 1325 1336
47. Bell T.J. Cell-specific alternative splicing increases calcium channel current density in the pain pathway Neuron 41 2004 127 138
48. Snutch, T.P. et al. (2003) Novel N-type calcium channel blockers efficacious in animal models of chronic pain. 226th American Chemical Society National Meeting, New York, NY
49. Snutch, T.P. (2004) N-type channels, small organic molecules and pain. Spring Pain Research Conference, Grand Cayman, BWI
50. Curran M.P., Wagstaff A.J. Gabapentin: in postherpetic neuralgia CNS Drugs 17 2003 975 982
51. Morello C.M. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain Arch. Intern. Med. 159 1999 1931 1937
52. Levendoglu F. Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury Spine 29 2004 743 751
53. Caraceni A. Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group J. Clin. Oncol. 22 2004 2909 2917
54. Lesser H. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial Neurology 63 2004 2104 2110
55. Rosenstock J. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial Pain 110 2004 628 638
56. Richter R.W. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial J. Pain 6 2005 253 260
57. Crofford L.J. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial Arthritis Rheum. 52 2005 1264 1273
58. Dworkin R.H. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial Neurology 60 2003 1274 1283
59. Arikkath J., Campbell K.P. Auxiliary subunits: essential components of the voltage-gated calcium channel complex Curr. Opin. Neurobiol. 13 2003 298 307
60. Gee N.S. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel J. Biol. Chem. 271 1996 5768 5776
61. Stahl S.M. Mechanism of action of alpha2delta ligands: voltage sensitive calcium channel (VSCC) modulators J. Clin. Psychiatry 65 2004 1033 1034
62. Field, M.J. (2004) Pregabalin's analgesic actions are mediated by its binding to the alpha2-delta type 1 subunit of voltage-gated calcium channels. Spring Pain Research Conference, Grand Cayman, BWI
63. Stefani A. Gabapentin inhibits calcium currents in isolated rat brain neurons Neuropharmacology 37 1998 83 91
64. Alden K.J., Garcia J. Differential effect of gabapentin on neuronal and muscle calcium currents J. Pharmacol. Exp. Ther. 297 2001 727 735
65. Stefani A. The effects of gabapentin on different ligand- and voltage-gated currents in isolated cortical neurons Epilepsy Res. 43 2001 239 248
66. Sutton K.G. Gabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neurones Br. J. Pharmacol. 135 2002 257 265
67. McClelland D. A study comparing the actions of gabapentin and pregabalin on the electrophysiological properties of cultured DRG neurones from neonatal rats BMC Pharmacol. 4 2004 14
68. Bayer K. Gabapentin may inhibit synaptic transmission in the mouse spinal cord dorsal horn through a preferential block of P/Q-type Ca2+ channels Neuropharmacology 46 2004 743 749
69. Rock D.M. Gabapentin actions on ligand- and voltage-gated responses in cultured rodent neurons Epilepsy Res. 16 1993 89 98
70. Schumacher T.B. Effects of phenytoin, carbamazepine, and gabapentin on calcium channels in hippocampal granule cells from patients with temporal lobe epilepsy Epilepsia 39 1998 355 363
71. van Hooft J.A. Gabapentin inhibits presynaptic Ca(2+) influx and synaptic transmission in rat hippocampus and neocortex Eur. J. Pharmacol. 449 2002 221 228
72. Dooley D.J. Preferential action of gabapentin and pregabalin at P/Q-type voltage-sensitive calcium channels: inhibition of K+-evoked [3H]-norepinephrine release from rat neocortical slices Synapse 45 2002 171 190
73. Brown J.T., Randall A. Gabapentin fails to alter P/Q-type Ca2+ channel-mediated synaptic transmission in the hippocampus in vitro Synapse 55 2005 262 269
74. Martin D.J. Gabapentin-mediated inhibition of voltage-activated Ca2+ channel currents in cultured sensory neurones is dependent on culture conditions and channel subunit expression Neuropharmacology 42 2002 353 366
75. Fehrenbacher J.C. Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C Pain 105 2003 133 141
76. Maneuf Y.P. Reduction by gabapentin of K+-evoked release of [3H]-glutamate from the caudal trigeminal nucleus of the streptozotocin-treated rat Br. J. Pharmacol. 141 2004 574 579
77. Coderre T.J. Evidence that gabapentin reduces neuropathic pain by inhibiting the spinal release of glutamate J. Neurochem. 94 2005 1131 1139
78. Kaneko M. Intrathecally administered gabapentin inhibits formalin-evoked nociception and the expression of Fos-like immunoreactivity in the spinal cord of the rat J. Pharmacol. Exp. Ther. 292 2000 743 751
79. Gottrup H. Chronic oral gabapentin reduces elements of central sensitization in human experimental hyperalgesia Anesthesiology 101 2004 1400 1408
80. Field M.J. Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents Br. J. Pharmacol. 121 1997 1513 1522
81. Hunter J.C. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain Eur. J. Pharmacol. 324 1997 153 160
82. Wallin J. Gabapentin and pregabalin suppress tactile allodynia and potentiate spinal cord stimulation in a model of neuropathy Eur. J. Pain 6 2002 261 272
83. Coulter D.A. Calcium currents in rat thalamocortical relay neurones: kinetic properties of the transient, low-threshold current J. Physiol. 414 1989 587 604
84. Huguenard J.R., Prince D.A. A novel T-type current underlies prolonged Ca(2+)-dependent burst firing in GABAergic neurons of rat thalamic reticular nucleus J. Neurosci. 12 1992 3804 3817
85. Scroggs R.S., Fox A.P. Calcium current variation between acutely isolated adult rat dorsal root ganglion neurons of different size J. Physiol. 445 1992 639 658
86. Scroggs R.S., Fox A.P. Multiple Ca2+ currents elicited by action potential waveforms in acutely isolated adult rat dorsal root ganglion neurons J. Neurosci. 12 1992 1789 1801
87. Cribbs L.L. Cloning and characterization of alpha1H from human heart, a member of the T-type Ca2+ channel gene family Circ. Res. 83 1998 103 109
88. Perez-Reyes E. Molecular characterization of a neuronal low-voltage-activated T-type calcium channel Nature 391 1998 896 900
89. Lee J.H. Cloning and expression of a novel member of the low voltage-activated T-type calcium channel family J. Neurosci. 19 1999 1912 1921
90. Talley E.M. Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels J. Neurosci. 19 1999 1895 1911
91. Lee J.H. Nickel block of three cloned T-type calcium channels: low concentrations selectively block alpha1H Biophys. J. 77 1999 3034 3042
92. + channels Biochem. Biophys. Res. Commun. 299 2002 562 568
93. Gao B. Functional properties of a new voltage-dependent calcium channel alpha(2)delta auxiliary subunit gene (CACNA2D2) J. Biol. Chem. 275 2000 12237 12242
94. Klugbauer N. A family of gamma-like calcium channel subunits FEBS Lett. 470 2000 189 197
95. Pape H.C. Novel vistas of calcium-mediated signalling in the thalamus Pflugers Arch. 448 2004 131 138
96. Isope P., Murphy T.H. Low threshold calcium currents in rat cerebellar Purkinje cell dendritic spines are mediated by T-type calcium channels J. Physiol. 562 2005 257 269
97. Suzuki S., Rogawski M.A. T-type calcium channels mediate the transition between tonic and phasic firing in thalamic neurons Proc. Natl. Acad. Sci. U. S. A. 86 1989 7228 7232
98. White G. Transient low-threshold Ca2+ current triggers burst firing through an after-depolarizing potential in an adult mammalian neuron Proc. Natl. Acad. Sci. U. S. A. 86 1989 6802 6806
99. Llinas R.R. Thalamocortical dysrhythmia: A neurological and neuropsychiatric syndrome characterized by magnetoencephalography Proc. Natl. Acad. Sci. U. S. A. 96 1999 15222 15227
100. Todorovic S.M., Lingle C.J. Pharmacological properties of T-type Ca2+ current in adult rat sensory neurons: effects of anticonvulsant and anesthetic agents J. Neurophysiol. 79 1998 240 252
101. Lancaster E. Calcium and calcium-activated currents in vagotomized rat primary vagal afferent neurons J. Physiol. 540 2002 543 556
102. Baccei M.L., Kocsis J.D. Voltage-gated calcium currents in axotomized adult rat cutaneous afferent neurons J. Neurophysiol. 83 2000 2227 2238
103. Abdulla F.A., Smith P.A. Axotomy- and autotomy-induced changes in Ca2+ and K+ channel currents of rat dorsal root ganglion neurons J. Neurophysiol. 85 2001 644 658
104. Hogan Q.H. Painful neuropathy decreases membrane calcium current in mammalian primary afferent neurons Pain 86 2000 43 53
105. McCallum J.B. Loss of T-type calcium current in sensory neurons of rats with neuropathic pain Anesthesiology 98 2003 209 216
106. Smith M.R. Regulation of firing response gain by calcium-dependent mechanisms in vestibular nucleus neurons J. Neurophysiol. 87 2002 2031 2042
107. Wolfart J., Roeper J. Selective coupling of T-type calcium channels to SK potassium channels prevents intrinsic bursting in dopaminergic midbrain neurons J. Neurosci. 22 2002 3404 3413
108. Ikeda H. Synaptic plasticity in spinal lamina I projection neurons that mediate hyperalgesia Science 299 2003 1237 1240
109. Herrero J.F. Wind-up of spinal cord neurones and pain sensation: much ado about something? Prog. Neurobiol. 61 2000 169 203
110. Joksovic P.M. Different kinetic properties of two T-type Ca2+ currents of rat reticular thalamic neurones and their modulation by enflurane J. Physiol. 566 2005 125 142
111. Jeanmonod D. Thalamus and neurogenic pain: physiological, anatomical and clinical data Neuroreport 4 1993 475 478
112. Kim D. Thalamic control of visceral nociception mediated by T-type Ca2+ channels Science 302 2003 117 119
113. Coulter D.A. Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons Ann. Neurol. 25 1989 582 593
114. Gomora J.C. Block of cloned human T-type calcium channels by succinimide antiepileptic drugs Mol. Pharmacol. 60 2001 1121 1132
115. Leresche N. On the action of the anti-absence drug ethosuximide in the rat and cat thalamus J. Neurosci. 18 1998 4842 4853
116. Matthews E.A., Dickenson A.H. Effects of ethosuximide, a T-type Ca(2+) channel blocker, on dorsal horn neuronal responses in rats Eur. J. Pharmacol. 415 2001 141 149
117. Gogas K.R. Effects of the T-type calcium channel blocker, Ethosuximide, in rodent models of acute and chronic pain. IASP 10th World Congress on Pain, San Diego, CA 2002
118. Dogrul A. Reversal of experimental neuropathic pain by T-type calcium channel blockers Pain 105 2003 159 168
119. Flatters S.J., Bennett G.J. Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy Pain 109 2004 150 161
120. Shannon H.E. Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats Neuropharmacology 48 2005 1012 1020
121. Eggers A.E., Moreno H. Suggestion for another anti-epileptic drug to use for migraine prophylaxis Headache 42 2002 696 697
122. Suzuki S. Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex Epilepsy Res. 12 1992 21 27
123. Kito M. Mechanisms of T-type calcium channel blockade by zonisamide Seizure 5 1996 115 119
124. Drake M.E. Jr Open-label zonisamide for refractory migraine Clin. Neuropharmacol. 27 2004 278 280
125. Takahashi Y. Successful use of zonisamide for central poststroke pain J. Pain 5 2004 192 194
126. Hord A.H. The effect of systemic zonisamide (Zonegran) on thermal hyperalgesia and mechanical allodynia in rats with an experimental mononeuropathy Anesth. Analg. 96 2003 1700 1706
127. Todorovic S.M. Mechanical and thermal antinociception in rats following systemic administration of mibefradil, a T-type calcium channel blocker Brain Res. 951 2002 336 340
128. + channels Mol. Pharmacol. 66 2004 1652 1661
129. Ertel E.A. Nomenclature of voltage-gated calcium channels Neuron 25 2000 533 535